Neurocrine Biosciences (NBIX) Tops Q3 EPS by 58c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $161.62 +2.10%
EPS Growth %: -5.5%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -5.5%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $2.17, $0.58 better than the analyst estimate of $1.59. Revenue for the quarter came in at $794.9 million versus the consensus estimate of $748.62 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Catheter Precision (VTAK) files for 68.07M share offering by selling stockholders
- Montana-Dakota Utilities signs power deal with Applied Digital for 430 MW AI campus
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
